Here are five key notes:
1. Mr. Delp will assume the role of president, Americas, previously held by Stuart G. Kleopfer, who decided to retire. Mr. Kleopfer was a leader with Biomet before the merger with Zimmer.
2. The leadership transition will take place Jan. 23, 2017. Mr. Kleopfer will continue with the company for a time and work closely with Mr. Delp as he fully assumes his new responsibilities.
3. Mr. Delp has previous experience as Zimmer Biomet’s vice president of U.S. sales where he led the sales for the knee, hip, bone cement, biologics, extremities, sports medicine, foot and ankle, surgical and trauma categories.
4. Mr. Delp has more than 20 years of experience in sales leadership.
5. Zimmer Biomet currently has operations in 25 countries and sells products in 100-plus countries.
More articles on orthopedic devices:
Zimmer Biomet, J&J, Stryker & more: 15 device company key notes
Spinal Simplicity brings patent count to 52—5 highlights
28 orthopedic, spine devices receive FDA 510(k) clearance in December 2016
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
